Completed
Study to Assess Tolerability and Safety and Antibody Response to G17DT in Gastric Cancer Patients
NCT02518529
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +6 more
- Locations
-
Not specified